2seventy bio Inc (NASDAQ:TSVT) price on Friday, March 21, remained unchanged to $4.95.
A look at the stock’s price movement, the close in the last trading session was $4.95, moving within a range at $4.95 and $4.96. The beta value (5-Year monthly) was 1.736. Turning to its 52-week performance, $5.99 and $2.29 were the 52-week high and 52-week low respectively. Overall, TSVT moved 84.70% over the past month.
2seventy bio Inc’s market cap currently stands at around $258.88 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-11.
Analysts have a consensus estimate of 13.03M for the company’s revenue for the quarter, with a low and high estimate of 10.27M and 17.5M respectively. The average forecast suggests up to a 22.00% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 49.89M, representing a -50.30% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TSVT is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 5 recommend TSVT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TSVT’s current price about 34.26% and 65.46% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 81.57, while 7-day volatility ratio is 0.26% and 5.11% in the 30-day chart. Further, 2seventy bio Inc (TSVT) has a beta value of 1.14, and an average true range (ATR) of 0.20. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $5. Looking at the price targets, the low is -1.01% off current price level while to achieve the yearly target high, price needs to move -1.01%. Nonetheless, investors will most likely welcome a -1.01% jump to $5 which is the analysts’ median price.
If we refocus on 2seventy bio Inc (NASDAQ:TSVT), historical trading data shows that trading volumes averaged 4.57 over the past 10 days and 1.04 million over the past 3 months. The company’s latest data on shares outstanding shows there are 51.51 million shares.
The 8.63% of 2seventy bio Inc’s shares are in the hands of company insiders while institutional holders own 85.74% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.8 million on 2025-02-28, giving us a short ratio of 17.13. The data shows that as of 2025-02-28 short interest in 2seventy bio Inc (TSVT) stood at 1126.0 of shares outstanding, with shares short falling to 5.18 million registered in 2025-01-31. Current price change has pushed the stock 68.37% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TSVT stock continues to rise going into the next quarter.
